Trending News Today: Allergan Pledges to Limit Drug Cost Increases

Top news of the day from across the healthcare landscape.

The uninsured rate dropped again in early 2016, with only 8.6% of respondents reporting they did not have health insurance. The previous study from the US Centers for Disease Control and Prevention (CDC) reported the figure would be 9.1%, according to The Wall Street Journal. While there are 1.3 million more people insured than expected, the CDC said the new figure is not statistically significant.

Allergan CEO Brent Saunders recently said the company will only increase prices once per year, and the increases will only be slightly over the price of inflation. The company is limiting increases due to the actions of other drugmakers that have created large increases in the cost of medications. Allergan’s price increases reflect this statement thus far, and they plan to continue doing this into the future, according to The New York Times.

New York’s attorney general has launched an investigation into whether Mylan limited competition for its product, EpiPen. Potentially anticompetitive terms were found in sales contracts with school systems during a preliminary review, according to The Washington Post. However, a Mylan spokesperson said the company has adhered to laws and regulations regarding the contracts.